You are here

Recent research demonstrates the growing role inflammatory markers play in heart disease. Results from the JUPITER study, issued at the recent American Heart Association Annual Meeting and published in the New England Journal of Medicine, demonstrate that patients with normal cholesterol but high levels of high-sensitivity C-reactive protein (hs-CRP), can lower their risk of suffering a heart attack or stroke with statin therapy.